Study on HIF-PHI combined with iron supplement in treatment of renal anemia in rats
Abstract Background Roxadustat is a novel hypoxia- inducible factor-prolyl hydroxylase inhibitor(HIF-PHI) used to treat anemia in chronic kidney disease (CKD) patients. It has been reported that roxadustat can slow down kidney damage and delay the development of kidney fibrosis. Anemia and iron defi...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2025-03-01
|
| Серія: | BMC Nephrology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12882-025-04045-y |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|